Literature DB >> 15277653

The epidemiology of the Lambert-Eaton myasthenic syndrome in the Netherlands.

P W Wirtz1, J G van Dijk, P A van Doorn, B G M van Engelen, A J van der Kooi, J B Kuks, A Twijnstra, M de Visser, L H Visser, J H Wokke, A R Wintzen, J J Verschuuren.   

Abstract

Entities:  

Mesh：

Year:  2004        PMID： 15277653     DOI： 10.1212/01.wnl.0000130254.27019.14

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  10 in total

Review 1.  Immune mediated diseases and immune modulation in the neurocritical care unit.

Authors:  Gloria von Geldern; Thomas McPharlin; Kyra Becker
Journal:  Neurotherapeutics       Date:  2012-01       Impact factor: 7.620

Review 2.  Lambert-Eaton myasthenic syndrome (LEMS): a rare autoimmune presynaptic disorder often associated with cancer.

Authors:  Benedikt Schoser; Bruno Eymard; Joe Datt; Renato Mantegazza
Journal:  J Neurol       Date:  2017-06-12       Impact factor: 4.849

3.  Lambert-Eaton Myasthenic Syndrome in Lung Cancer.

Authors:  Yongbin Wang; Chuanguo Xu; Yu Wang; Feifei Feng; Hui Wang; Ying Zhang; Xiaojuan Lin; Bin Xu
Journal:  Contrast Media Mol Imaging       Date:  2022-07-05       Impact factor: 3.009

4.  Epidemiology of myasthenia gravis in Austria: rising prevalence in an ageing society.

Authors:  Hakan Cetin; Gerhard Fülöp; Heidemarie Zach; Eduard Auff; Fritz Zimprich
Journal:  Wien Klin Wochenschr       Date:  2012-11-06       Impact factor: 1.704

Review 5.  Effectiveness, safety and costs of orphan drugs: an evidence-based review.

Authors:  Igho J Onakpoya; Elizabeth A Spencer; Matthew J Thompson; Carl J Heneghan
Journal:  BMJ Open       Date:  2015-06-24       Impact factor: 2.692

Review 6.  The association between Lambert-Eaton myasthenic syndrome and small cell lung carcinoma.

Authors:  Sarah Ew Briggs; Paul Gozzard; Denis C Talbot
Journal:  Immunotargets Ther       Date:  2013-05-21

Review 7.  Lambert-Eaton Myasthenic syndrome: early diagnosis is key.

Authors:  Trajche Ivanovski; Francesc Miralles
Journal:  Degener Neurol Neuromuscul Dis       Date:  2019-05-13

8.  Nationwide survey of Lambert-Eaton myasthenic syndrome in Japan.

Authors:  Hiroaki Yoshikawa; Yumi Adachi; Yosikazu Nakamura; Nagato Kuriyama; Hiroyuki Murai; Yoshiko Nomura; Yasunari Sakai; Kazuo Iwasa; Yutaka Furukawa; Satoshi Kuwabara; Makoto Matsui
Journal:  BMJ Neurol Open       Date:  2022-09-05

9.  Lung adenocarcinoma with Lambert-Eaton myasthenic syndrome indicated by voltage-gated calcium channel: a case report.

Authors:  Hiromasa Arai; Kenji Inui; Kazuki Hashimoto; Kazuki Kan-O; Teppei Nishii; Hitaru Kishida; Koji Okudela; Masahiro Tsuboi; Akinori Nozawa; Takeshi Kaneko; Munetaka Masuda
Journal:  J Med Case Rep       Date:  2012-09-05

10.  Long-term follow-up, quality of life, and survival of patients with Lambert-Eaton myasthenic syndrome.

Authors:  Alexander F Lipka; Marion I Boldingh; Erik W van Zwet; Marco W J Schreurs; Jan B M Kuks; Chantal M Tallaksen; Maarten J Titulaer; Jan J G M Verschuuren
Journal:  Neurology       Date:  2019-12-12       Impact factor: 9.910
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.